Home - Official Website of West Java Province

berita

Official Website of West Java Province
  • Main Menu
  • Tidak ada polling untuk saat ini.

    Bio Farma Received National Children's Award

    http://jabarprov.go.id/En/assets/images/berita/gambar_4645.jpg

    JAKARTA-Bio Farma received appreciation of the National Children's Award in the field of Pharmacy and Medical Device submitted directly by the Minister of Health, Nila F. Moeloek, to Juliman Acting President Director of Bio Farma, at the Jakarta International Expo Kemayoran, Thursday (9/11).
     
    From the release of Bio Farma PR, awarding together with the National Health Day (HKN) to-53. Also present Coordinating Minister for Economic Affairs, Darmin Nasution, who delivered speeches and opened the exhibition of health development and Production of Medical Devices in the country.

    "Jokowi JK Government not only build infrastructure as well as build education and health, including supporting institutional financing of health facilities such as BPJS" said Darmin in his speech.
     
    A total of 10 companies received the award, consisting of Health Equipment Industry category such as PT. Enesers Mitra Berkah, PT. Jayamas Medica Industri, PT. Swayasa Prakarsa, PT. Tesena Inovindo, PT. Triton Manufactures, PT. Zenith Almart Precisindo.
     
    While the category of Pharmaceutical Industry is PT. Daewoong Infion, PT. SOHO Industri Pharmasi, PT. Martina Berto, Tbk, and PT. Bio Farma (Persero) became the only state-owned company that received this award.
     
    Juliman, Acting President Director of Bio Farma conveyed "We express our gratitude for the appreciation given by the Government through the Ministry of Health. as our state-owned company has a responsibility to ensure that vaccine procurement, especially in this sector of the government, can be maintained, we strongly prioritize the need for domestic vaccines, especially to support the national immunization program, "he said. (Even)

    Share |

    RELATED NEWS :

    COMMENTS
    Comments powered by Disqus